This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovations of Caiyun Pan
Introduction
Caiyun Pan is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on drug formulations. His expertise and dedication have led to the development of a unique pharmaceutical composition that has garnered attention in the medical community.
Latest Patents
Caiyun Pan holds 1 patent for a pharmaceutical composition. This patent specifically relates to abiraterone acetate, where a 300 mg dose is bioequivalent to a 1000 mg dose of Zytiga® in healthy male subjects in a fasting state. This innovation has the potential to improve treatment options for patients requiring this medication.
Career Highlights
Caiyun Pan is currently employed at Jiangsu Hengrui Pharmaceuticals Co., Ltd. His work at this leading pharmaceutical company has allowed him to focus on developing advanced drug formulations that enhance therapeutic efficacy. His contributions are vital in the ongoing efforts to improve patient care through innovative pharmaceutical solutions.
Collaborations
Caiyun Pan collaborates with talented professionals in his field, including Ailing Chen and Kai Pan. These partnerships foster a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical innovations.
Conclusion
Caiyun Pan's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of abiraterone acetate, highlight the importance of research and development in improving patient outcomes.